DMPX
![]()  | |
| Clinical data | |
|---|---|
| ATC code | 
  | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.162.258 | 
| Chemical and physical data | |
| Formula | C10H10N4O2 | 
| Molar mass | 218.216 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
InChI 
  | |
DMPX (3,7-dimethyl-1-propargylxanthine) is a caffeine analog which displays affinity to A2 adenosine receptors, in contrast to the A1 subtype receptors.[1] DMPX had 28× and 15× higher potency than caffeine in blocking peripheral and central NECA-responses. The locomotor stimulation caused by DMPX (ED50 10 μmol/kg) was similarly higher than caffeine.[1]
See also
- DPCPX
 - 8-PT
 - CPX (8-CPT)
 - 8-Chlorotheophylline
 - Theophylline
 
References
- 1 2 Seale TW, Abla KA, Shamim MT, Carney JM, Daly JW (1988). "3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs". Life Sciences. 43 (21): 1671–84. doi:10.1016/0024-3205(88)90478-x. PMID 3193854.
 
Purine receptor modulators  | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Receptor (ligands)  | 
  | ||||||||||
| Transporter (blockers)  | 
  | ||||||||||
| Enzyme (inhibitors)  | 
  | ||||||||||
| Others | 
 
  | ||||||||||
See also: Receptor/signaling modulators  | |||||||||||
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
